bioMerieux SA Launches a Molecular Biology Test for the Detection of HPV, a Major Cause of Cervical Cancer

April 23, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MARCY L'ETOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris: BIM) announces the launch of its NucliSENS EasyQ® HPV; this molecular diagnostic test enables the detection of human papillomavirus (HPV) in cervical cancer surveillance.

Twitter
LinkedIn
Facebook
Email
Print

Europe